Application of glucocorticoids in treatment of COVID-19.
Chinese Journal of Clinical Infectious Diseases
; 14(1):21-23, 2021.
Article
in Chinese
| EMBASE | ID: covidwho-2261584
ABSTRACT
The infection of 2019-nCoV can lead to overexpression of inflammatory factors, triggering cytokine storm and causing serious damage to the body. Glucocorticoids have anti-inflammatory properties and may be an effective treatment option. The use and dosage of glucocorticoids in coronavirus disease 2019 (COVID-19) remains controversial. This article reviews the theoretical basis, clinical evidence, debates and specific measures of glucocorticoids in the treatment of COVID-19, to provide reference for rational application of glucocorticoids in the future.Copyright © 2021 Chinese Medical Association
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Chinese
Journal:
Chinese Journal of Clinical Infectious Diseases
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS